Related references
Note: Only part of the references are listed.Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants
Kyoko Yoshida et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
Tai-Chung Tseng et al.
LIVER CANCER (2020)
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
Lilian Yan Liang et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Novel biomarkers for the management of chronic hepatitis B
Takako Inoue et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2019)
Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma
Wai-Pan To et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia
Kali Zhou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues
Tetsuya Hosaka et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection
Hye Won Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment
Yusuke Ando et al.
HEPATOLOGY RESEARCH (2018)
Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone
M. Bonacci et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers
Toshifumi Tada et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Determination of hepatitis B phenotype using biochemical and serological markers
A. M. Di Bisceglie et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong et al.
LIVER INTERNATIONAL (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Yuk-Fai Lam et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Elimination of Hepatitis B: Is It a Mission Possible?
Tai-Chung Tseng et al.
BMC MEDICINE (2017)
Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma
Masao Honda et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
Jessica Liu et al.
HEPATOLOGY (2016)
HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics
Toshifumi Tada et al.
JOURNAL OF HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
B. Maasoumy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation
Toshihisa Matsuzaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2013)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
New insight in the pathobiology of hepatitis B virus infection
Maura Dandri et al.
GUT (2012)
Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B Patients
Fumitaka Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis
Shijian Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers
CJ Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prevalence of HBV precore/core promoter variants in the United States
CJ Chu et al.
HEPATOLOGY (2003)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
JH Kao et al.
GASTROENTEROLOGY (2003)
Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus
MF Yuen et al.
JOURNAL OF INFECTIOUS DISEASES (2002)